VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock

ISNES, Belgium, March 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers, announced today the closing of...

Leave a comment

Your email address will not be published.